Obesity is now recognized as a neuroendocrine disease caused by dysfunction in the brain’s appetite-regulating systems. The hypothalamus integrates signals from hormones like leptin, insulin, and ghrelin to control hunger and energy balance. In obesity, this system becomes dysregulated — due to leptin resistance, hypothalamic inflammation, and altered reward pathways — leading to persistent hunger and overeating even when energy stores are full. Highly processed foods further overstimulate dopamine-driven reward circuits, reinforcing compulsive eating. Modern research shows that obesity is not simply about excess calories, but a complex interaction between the brain, hormones, metabolism, and environment — calling for targeted, biology-based treatments."

Key Mechanisms That Explain Obesity as a Neuroendocrine Disease

• Hypothalamic Dysregulation
  Impaired central control of appetite and energy homeostasis

• Leptin Resistance
  High leptin levels fail to suppress hunger signals

• Hypothalamic Inflammation
  Chronic nutrient excess disrupts neuronal signaling

• Dopamine Reward Dysfunction
  Hyperpalatable foods drive addictive eating behaviors

• Gut–Brain Axis Alterations
  Microbiota influence appetite, inflammation, and metabolism

• Lipid Signaling (Ceramides)
  Neurotoxic lipids impair metabolic and neuronal function

• Metabolic Crosstalk (Liver–Brain Axis)
  Conditions like fatty liver amplify systemic metabolic dysfunction

Obesity is no longer seen as simple overeating. It is a complex neuroendocrine disorder rooted in the brain’s control of appetite, metabolism, and reward. At its center is the hypothalamus — a small but powerful region that integrates signals like leptin, insulin, and ghrelin to balance hunger and satiety. In obesity, this system becomes dysregulated, causing persistent hunger and weight gain even when calories are plentiful (Sun et al., 2025).

One of the most critical disruptions in this process is leptin resistance, a state in which the brain fails to respond to high circulating leptin levels. Instead of suppressing appetite, the hypothalamus behaves as if the body is in a state of energy deprivation, driving increased food intake and decreased energy expenditure (Tan et al., 2025; Argente et al., 2025). This phenomenon helps explain why traditional calorie-restriction strategies often fail in the long term and why weight regain is so common.

Adding another layer of complexity, modern food environments interact with the brain’s reward pathways, particularly dopaminergic circuits that evolved to reinforce survival behaviors. Highly processed, energy-dense foods overstimulate these pathways, promoting hedonic eating, food cravings, and patterns that resemble addiction (Maqsood et al., 2025). Emerging evidence also highlights the role of hypothalamic inflammation, lipid signaling (such as ceramides), and gut-brain interactions in further amplifying this dysregulation (Le Stunff et al., 2025; Zhang et al., 2025).

Together, these mechanisms redefine obesity—not as a failure of willpower—but as a biologically driven condition requiring targeted, science-based interventions.

Clinical Pearls

1. The "Broken Fuel Gauge" (Leptin Resistance)

• Scientific Perspective: Leptin resistance is characterized by a failure of high circulating leptin levels to suppress appetite or increase energy expenditure. This is often driven by hypothalamic inflammation and the overactivation of SOCS3, which blocks the JAK-STAT signaling pathway, effectively "blinding" the brain to the body's fat stores.

• Imagine your body is a car with a full tank of gas, but the fuel gauge is stuck on "Empty." Even though you have plenty of energy stored, your brain thinks you are starving. This is why you feel ravenous even when you’ve had enough to eat—it’s not a lack of willpower; it's a broken sensor.

2. The "Brain on Fire" (Hypothalamic Inflammation)

• Scientific Perspective: Overnutrition, particularly from saturated fats and refined sugars, triggers an innate immune response in the microglial cells of the hypothalamus. This local "gliosis" occurs rapidly—often before significant weight gain—and disrupts the delicate balance between hunger-promoting (NPY/AgRP) and satiety-promoting (POMC) neurons.

• Think of highly processed foods as a "brain irritant." They cause a tiny amount of "swelling" in the part of your brain that controls hunger. This "brain fire" makes your hunger switch get stuck in the "ON" position, making it nearly impossible to stop eating once you start.

3. The "Volume Control" of Reward (Dopamine Downregulation)

• Scientific Perspective: Chronic consumption of hyperpalatable foods leads to a decrease in D2 receptor availability in the striatum. This neuroadaptation means the individual requires greater "stimulus intensity" (more sugar/fat) to achieve the same dopaminergic reward, mirroring the biological pathways of substance addiction.

• Your brain has a volume knob for pleasure. When you constantly blast it with loud "music" (sugar, salt, and fat), the brain protects itself by turning the volume down. Now, "quiet" healthy foods like broccoli don't taste like anything, and you find yourself needing "louder" junk food just to feel a normal sense of satisfaction.

4. The "Sleep-Hunger Connection" (Raptin & Ghrelin)

• Scientific Perspective: Sleep deprivation is a primary endocrine disruptor. It suppresses Raptin (a novel 2025-identified appetite suppressant) and leptin, while simultaneously elevating Ghrelin (the hunger hormone) and endocannabinoids. This creates a state of "metabolic grogginess" that favors positive energy balance and weight gain.

• Sleep is when your brain produces its own "natural diet pill" (Raptin). When you skip sleep, that pill isn't made. Instead, your body produces a "hunger chemical" that makes you crave high-calorie snacks the next day. You aren't just tired; your hormones are literally begging you to overeat to compensate for the lack of rest.

5. The "Back-and-Forth Hotline" (The Gut-Brain Axis)

• Scientific Perspective: The gut microbiome produces Short-Chain Fatty Acids (SCFAs) like butyrate, which cross the blood-brain barrier to modulate hypothalamic NPY/AgRP activity. A dysbiotic microbiome lacks these metabolites, weakening the "satiety hotline" between the digestive tract and the central nervous system.

• Your gut and your brain are on a constant "hotline" call. Fiber and healthy fermented foods keep the connection crystal clear, telling your brain, "We're full down here!" Ultra-processed foods create "static" on the line, so the "I'm full" message never reaches your head, leaving you looking for more food even when your stomach is physically stretched.

Moving Beyond “Calories In, Calories Out”

The Neuroendocrine Shift: Why Modern Medicine is Rethinking Weight Loss

For decades, obesity was framed as a simple imbalance between energy intake and expenditure. However, modern research has fundamentally reshaped this view. Obesity is now recognized as a neuroendocrine disorder, where the brain—particularly the hypothalamus—integrates hormonal, nutrient, and environmental signals to regulate appetite, energy expenditure, and body weight.

This paradigm shift is critical for both clinicians and patients. It explains why:

• Weight regain is common after dieting

• Hunger persists despite adequate caloric intake

• Highly processed foods override satiety signals

At the center of this regulation lies a complex interplay between:

• Hypothalamic circuits

• Peripheral hormones (leptin, insulin, ghrelin)

• Reward pathways (dopamine signaling)

Understanding these mechanisms allows for targeted, biology-driven interventions rather than simplistic calorie restriction.

Why You Feel Hungry Even After Eating

“Feeling hungry soon after a meal usually reflects neuroendocrine dysregulation, not that you ate too little. The main driver is leptin resistance: even with enough calories, the hypothalamus keeps signaling hunger (Tan et al., 2025; Argente et al., 2025).

Other factors compound this: meals low in protein and fiber don’t fully activate satiety pathways (POMC/CART neurons); ultra-processed foods cause blood-sugar swings that stimulate appetite (Sun et al., 2025); dopamine-driven reward makes you crave more despite fullness (Maqsood et al., 2025); poor sleep raises ghrelin and lowers leptin (Xie et al., 2025); and a disrupted gut–brain axis weakens fullness signals (Zhang et al., 2025).

In short, it’s a mismatch between brain signaling, hormones, and food quality — not a lack of willpower.”

Why? Breaks the long block into shorter paragraphs for easier reading, combines the list slightly, and keeps every mechanism + citation + final reinforcing sentence.

1. Hypothalamic Regulation of Appetite: The Brain’s Metabolic Command Center

1.1 Key Hypothalamic Circuits

The hypothalamus acts as the central integrator of energy homeostasis. Within it, the arcuate nucleus (ARC) contains two critical neuronal populations:

Orexigenic (hunger-promoting) neurons

• Neuropeptide Y (NPY)

• Agouti-related peptide (AgRP)

Anorexigenic (satiety-promoting) neurons

• Pro-opiomelanocortin (POMC)

• Cocaine- and amphetamine-regulated transcript (CART)

These neurons respond dynamically to circulating signals:

• Leptin & insulin → suppress appetite

• Ghrelin → stimulates hunger

The output is transmitted to downstream regions such as the:

• Paraventricular nucleus (PVN)

• Lateral hypothalamus

This creates a tightly regulated feedback system controlling feeding behavior (Sun et al., 2025).

1.2 Hormonal Integration and Energy Sensing

The hypothalamus continuously monitors:

• Glucose levels

• Fatty acids

• Amino acids

• Gut-derived peptides

Emerging research highlights novel regulators such as raptin, a sleep-induced hypothalamic hormone that suppresses appetite and body weight—linking sleep physiology with metabolic control (Xie et al., 2025).

1.3 Hypothalamic Inflammation: A Turning Point in Obesity

One of the most important discoveries in obesity research is that overnutrition induces hypothalamic inflammation, leading to:

• Neuronal dysfunction

• Impaired leptin signaling

• Persistent hyperphagia

This inflammatory state may occur early in obesity, even before significant weight gain (Argente et al., 2025).

2. Leptin Resistance: The Failure of the Satiety Signal

2.1 What is Leptin?

Leptin is a hormone secreted by adipose tissue that signals energy sufficiency to the brain. Under normal physiology:

• Increased fat mass → increased leptin

• Increased leptin → decreased appetite

However, in obesity:

Leptin levels are high, yet appetite remains elevated.

This paradox is known as leptin resistance.

2.2 Mechanisms of Leptin Resistance

“Recent studies (Tan et al., 2025; Argente et al., 2025) highlight four key pathways:

1. Impaired transport — less leptin reaches the hypothalamus across the blood-brain barrier.

2. Signaling defects inside the cell — SOCS3 overactivation blocks the JAK-STAT pathway.

3. Lipid toxicity — ceramides build up and disrupt neuronal signaling (Le Stunff et al., 2025).

4. ER stress — chronic nutrient overload impairs normal protein folding.”

2.3 Ceramide Pathway: A Key Emerging Mechanism

Ceramides—bioactive lipid molecules—play a pivotal role in:

• Insulin resistance

• Neuronal dysfunction

• Appetite dysregulation

In the hypothalamus, ceramide accumulation:

• Disrupts POMC neuron function

• Promotes hyperphagia

• Impairs glucose homeostasis (Le Stunff et al., 2025)

2.4 Clinical Implications of Leptin Resistance

Leptin resistance explains:

• Why dieting increases hunger

• Why weight loss plateaus occur

• Why long-term maintenance is difficult

It also supports the use of:

• GLP-1 receptor agonists

• Combination therapies targeting central pathways

3. Reward Pathways and Food Addiction Biology

3.1 The Dopamine System and Hedonic Eating

Beyond homeostatic regulation, eating behavior is strongly influenced by reward circuitry, particularly:

• Ventral tegmental area (VTA)

• Nucleus accumbens

Highly palatable foods:

• Increase dopamine release

• Reinforce eating behavior independent of energy needs

3.2 Food Addiction: Myth or Reality?

Growing evidence supports the concept of food addiction, characterized by:

• Loss of control over intake

• Craving and withdrawal-like symptoms

• Continued consumption despite harm

A comprehensive review (Maqsood et al., 2025) highlights:

• Neurobiological overlap with substance addiction

• Altered dopamine receptor signaling

• Behavioral reinforcement loops

3.3 Ultra-Processed Foods and Neuroadaptation

Ultra-processed foods:

• Combine sugar, fat, and salt in hyper-palatable ratios

• Bypass natural satiety mechanisms

• Promote compulsive overeating

Chronic exposure leads to:

• Dopamine receptor downregulation

• Increased reward threshold

• Escalation of intake

3.4 Gut-Brain Axis and Reward Modulation

The gut microbiome influences:

• Neurotransmitter production

• Appetite hormones

• Inflammation

Microbiota-derived metabolites (e.g., SCFAs, bile acids):

• Modulate hypothalamic signaling

• Influence reward behavior (Zhang et al., 2025)

4. Integrating the Systems: A Unified Neuroendocrine Model of Obesity

Modern obesity can be conceptualized as a multi-level dysregulation:

Based on the 2026 unified neuroendocrine model, the dysfunctions driving obesity can be categorized into four primary systems. This structural breakdown shows how the disease moves from the brain to the peripheral organs:

The Multi-Level Dysregulation of Obesity

• Hypothalamic System (The Command Center)

  • Dysfunction: Impaired Energy Sensing.

  • Clinical Impact: The brain’s "thermostat" becomes broken. It loses the ability to accurately monitor incoming nutrients and energy stores, leading to a persistent, biological drive to eat even when energy is abundant.

• Hormonal System (The Signaling Network)

  • Dysfunction: Leptin & Insulin Resistance.

  • Clinical Impact: The "I’m full" signals (Leptin) and "Storage" signals (Insulin) are ignored by the cells. This creates a state of "internal starvation" where the brain ignores the fuel in the blood and signals for more intake.

• Reward System (The Hedonic Drive)

  • Dysfunction: Dopamine Dysregulation.

  • Clinical Impact: Chronic exposure to hyper-palatable foods "numbs" the reward center. Patients require larger "doses" of sugar, salt, and fat to feel a normal sense of pleasure, leading to compulsive overeating similar to chemical dependency.

• Peripheral Metabolism (The Target Organs)

  • Dysfunction: MAFLD & Systemic Insulin Resistance.

  • Clinical Impact: Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD) and muscle insulin resistance create a pro-inflammatory environment. This inflammation feeds back into the brain, further damaging the hypothalamus in a self-reinforcing cycle.

The "Silent Operator" Perspective

When explaining this to a patient, you might say: "Obesity isn't a single problem; it's a 'communication breakdown' between your brain's hunger switch, your hormones, your pleasure centers, and your liver. When these four systems stop talking to each other, your body defaults to storing fat rather than burning it."

Notably, metabolic diseases such as fatty liver disease amplify this dysfunction through:

• Systemic inflammation

• Altered lipid metabolism

• Hormonal disruption (Cao et al., 2025)

5. Practical Applications: Translating Science into Clinical Strategy

5.1 Sleep Optimization

• 7–8 hours of sleep improves hypothalamic signaling

• Supports hormones like raptin

5.2 Protein and Fiber Prioritization

• Enhances satiety signaling

• Reduces reward-driven eating

5.3 Reduce Ultra-Processed Foods

• Minimizes dopamine overstimulation

• Restores natural appetite control

5.4 Exercise as Neuroendocrine Therapy

• Improves leptin sensitivity

• Reduces hypothalamic inflammation

5.5 Pharmacological Approaches

• GLP-1 receptor agonists

• Dual incretin therapies

• Emerging central-acting agents

6. Clinical Takeaways for Practitioners

• Obesity is not a failure of willpower, but a brain-driven disorder

• Leptin resistance is central to weight regain

• Reward pathways must be addressed alongside metabolic factors

• Multimodal therapy is essential (lifestyle + pharmacology)

Frequently Asked Questions: The Neurobiology of Obesity

1. Is obesity truly a "brain disease" or just a metabolic issue?

Obesity is a neuroendocrine disorder. While the metabolic consequences (like high blood sugar) happen in the body, the "management" happens in the brain. The hypothalamus serves as the central integrator, balancing hunger-promoting neurons (NPY/AgRP) and satiety-promoting neurons (POMC). When these circuits are disrupted by overnutrition and inflammation, the brain’s ability to regulate energy homeostasis fails, leading to persistent weight gain (Argente et al., 2025; Sun et al., 2025).

2. Why do I feel hungry immediately after eating a large meal?

This is primarily due to Leptin Resistance. Leptin is the hormone that tells your brain you have enough fat stores. In obesity, high levels of leptin fail to cross the blood-brain barrier effectively, or the signaling pathways (JAK-STAT) within the hypothalamus are blocked by SOCS3 overactivation and lipid toxicity (ceramides). Consequently, your brain perceives a state of "starvation" despite high energy availability, driving you to keep eating (Tan et al., 2025; Le Stunff et al., 2025).

3. Can leptin resistance be reversed, or is the damage permanent?

It is partially reversible through targeted interventions that reduce hypothalamic inflammation. Clinical evidence suggests that weight loss, consistent aerobic exercise, and high-quality sleep can "re-sensitize" the brain to leptin signals. Furthermore, reducing the intake of saturated fats and refined sugars helps clear ceramide buildup in the hypothalamus, restoring the function of POMC neurons (Argente et al., 2025; Le Stunff et al., 2025).

4. Are ultra-processed foods genuinely addictive?

Yes. Modern "hyper-palatable" foods (engineered combinations of fat, sugar, and salt) bypass the homeostatic hunger signals and target the mesolimbic dopamine system. Chronic exposure leads to dopamine receptor downregulation, meaning you need more of the food to feel the same "hit" of pleasure. This creates a behavioral reinforcement loop identical to substance use disorders (Maqsood et al., 2025).

5. How does sleep deprivation directly cause weight gain?

Sleep is a critical metabolic regulator. Lack of sleep suppresses Raptin, a newly identified 2025 hypothalamic hormone that naturally suppresses appetite and body weight. Simultaneously, sleep loss increases ghrelin (the hunger hormone) and decreases leptin, creating a hormonal "perfect storm" that drives cravings for high-density, rewarding foods (Xie et al., 2025).

6. What is the "Gut-Brain Axis" and how does it control my weight?

Your gut microbiome communicates with your brain via the Vagus nerve and the production of Short-Chain Fatty Acids (SCFAs). These metabolites influence hypothalamic signaling and reward behavior. A healthy microbiome sends "fullness" signals to the brain, while a dysbiotic (unhealthy) microbiome can trigger systemic inflammation that worsens leptin resistance (Zhang et al., 2025).

7. What is the most effective treatment approach in 2026?

The "gold standard" has shifted toward Multimodal Therapy. Because obesity is a multi-level dysregulation, treatment must address the hypothalamus (sleep and anti-inflammatory diet), reward pathways (behavioral strategies and reducing processed foods), and peripheral metabolism. This often includes a combination of lifestyle changes and targeted pharmacotherapy, such as GLP-1 receptor agonists or dual incretin therapies (Cassataro et al., 2026; Caturano et al., 2025).

Elite Editorial: Obesity as a Neuroendocrine Disorder (Scientific Perspective)

• Paradigm Shift in Obesity Science:
  Obesity should no longer be conceptualized as a passive consequence of caloric excess but as an active neuroendocrine dysregulation involving central energy-sensing circuits. The hypothalamus integrates peripheral metabolic signals and orchestrates adaptive responses; disruption of this system fundamentally alters energy homeostasis (Argente et al., 2025; Sun et al., 2025).

• Central Role of Hypothalamic Dysfunction:
  Early hypothalamic inflammation—triggered by nutrient excess—impairs neuronal plasticity and disrupts anorexigenic signaling pathways. This leads to persistent hyperphagia and altered metabolic set points, often preceding overt weight gain (Argente et al., 2025).

• Leptin Resistance as a Core Pathophysiological Driver:
  Despite elevated circulating leptin levels, impaired leptin signaling at the level of the hypothalamus perpetuates a state of perceived energy deficiency. Mechanistically, this involves SOCS3 upregulation, ER stress, and defective intracellular signaling cascades (Tan et al., 2025).

• Lipid Signaling and Ceramide Toxicity:
  Accumulation of hypothalamic ceramides represents a critical metabolic insult, linking overnutrition to neuronal dysfunction, impaired glucose homeostasis, and sustained appetite dysregulation (Le Stunff et al., 2025).

• Reward Circuitry and Hedonic Override:
  Beyond homeostatic control, obesity is reinforced by dopaminergic reward pathways, where hyperpalatable foods induce neuroadaptive changes analogous to addictive behaviors, promoting compulsive intake (Maqsood et al., 2025).

• Gut–Brain Axis Integration:
  Microbiota-derived metabolites modulate both hypothalamic signaling and reward pathways, highlighting a bidirectional axis influencing appetite, inflammation, and metabolic disease progression (Zhang et al., 2025).

• Clinical Implications:
  Effective obesity management must transcend calorie restriction and incorporate multi-target strategies addressing central signaling, metabolic inflammation, and behavioral reinforcement mechanisms.

• Future Direction:
  Therapeutic innovation lies in targeting neuroendocrine pathways—integrating pharmacology, lifestyle modulation, and precision nutrition to restore physiological appetite regulation.

Call to Action (CTA): Engage and Transform

If you found this evidence-based deep dive helpful:

• ✅ Share this article with patients or colleagues

• ✅ Bookmark for clinical reference

• ✅ Subscribe to drdidwal.com

Author’s Note (Clinical Perspective)

As a clinician managing patients with obesity, one of the most important lessons reinforced by emerging research is this: obesity is not a failure of discipline—it is a disorder of biology. In everyday practice, I routinely encounter individuals who have made repeated, sincere efforts to lose weight through calorie restriction and exercise, only to experience short-term success followed by weight regain. Traditional models often attribute this to non-adherence, but current evidence clearly indicates that underlying neuroendocrine dysregulation is a major driver of this cycle (Argente et al., 2025).

From a clinical standpoint, leptin resistance and hypothalamic dysfunction provide a compelling explanation for persistent hunger, reduced satiety, and metabolic adaptation during weight loss. Patients frequently report that their appetite feels “out of control” despite eating adequately—this is not subjective exaggeration but reflects altered central signaling pathways (Tan et al., 2025). Recognizing this shifts the therapeutic approach from blame to biologically informed intervention.

Equally relevant is the role of reward circuitry and food environment. In modern settings, patients are continuously exposed to hyperpalatable, ultra-processed foods that hijack dopaminergic pathways, reinforcing overeating behaviors beyond metabolic need (Maqsood et al., 2025). Addressing obesity, therefore, requires not only dietary counseling but also strategies to manage environmental triggers and behavioral conditioning.

In practice, effective management is multidimensional:

• Lifestyle interventions remain foundational but must be realistic and sustainable

• Pharmacotherapy (e.g., GLP-1 receptor agonists) plays an increasingly important role

• Sleep, stress, and circadian health are critical but often overlooked factors

Ultimately, the goal is to restore physiological regulation of appetite, not merely reduce caloric intake. As clinicians, embracing this neuroendocrine model allows us to deliver more compassionate, effective, and evidence-based care—improving both metabolic outcomes and patient trust.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Individual circumstances vary, and treatment decisions should always be made in consultation with qualified healthcare professionals.

Related Articles

Managing Diabesity: A Complete Guide to Weight Loss and Blood Sugar Control | DR T S DIDWAL

Weight Loss as Immunotherapy: The Science Behind Reversing Chronic Inflammation | DR T S DIDWAL

Your Body Fat Is an Endocrine Organ—And Its Hormones Shape Your Heart Health | DR T S DIDWAL

The Circadian Diet: Why When You Eat Matters More Than Calories for Weight Loss & Metabolic Health | DR T S DIDWAL

References

Argente, J., Farooqi, I. S., Chowen, J. A., Kühnen, P., López, M., Morselli, E., Gan, H. W., Spoudeas, H. A., Wabitsch, M., & Tena-Sempere, M. (2025). Hypothalamic obesity: From basic mechanisms to clinical perspectives. The Lancet Diabetes & Endocrinology. Advance online publication. https://doi.org/10.1016/S2213-8587(24)00283-3

Xie, L. Q., Hu, B., Lu, R. B., et al. (2025). Raptin, a sleep-induced hypothalamic hormone, suppresses appetite and obesity. Cell Research, 35, 165–185. https://doi.org/10.1038/s41422-025-01078-8

Le Stunff, H., Brasilio Villalta, P., & Magnan, C. (2025). Hypothalamic ceramide metabolism in obesity and dysregulation of glucose homeostasis. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-025-10003-8

Sun, X., Liu, B., Yuan, Y., Rong, Y., Pang, R., & Li, Q. (2025). Neural and hormonal mechanisms of appetite regulation during eating. Frontiers in Nutrition, 12, 1484827. https://doi.org/10.3389/fnut.2025.1484827

Zhang, Y., Liu, X., Wang, Y., Li, M., Chen, H., & Sun, Q. (2025). Gut microbiota–derived metabolites and metabolic diseases: Mechanisms and therapeutic implications. Journal of Diabetes Investigation. Advance online publication. https://doi.org/10.1016/j.jdiacomp.2025.100008

Cao, Y., Liu, Z., Zhang, H., Wang, X., & Li, S. (2025). Metabolic dysfunction–associated fatty liver disease and its cardiometabolic implications: Mechanisms and therapeutic strategies. Clinical and Translational Medicine. Advance online publication. https://doi.org/10.1016/j.s2049-3614(25)00142-x

Maqsood, S., Ahmed, F., Arshad, M. T., Ikram, A., & Abdullahi, M. A. (2025). Comparative analysis of food addiction and obesity: A critical review. Food Science & Nutrition, 13(8), e70799. https://doi.org/10.1002/fsn3.70799

Tan, B., Hedbacker, K., Kelly, L., Zhang, Z., Moura-Assis, A., Luo, J. D., Rabinowitz, J. D., & Friedman, J. M. (2025). A cellular and molecular basis of leptin resistance. Cell Metabolism, 37(3), 723–737. https://doi.org/10.1016/j.cmet.2025.01.001